Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2022-06-29 00:00:00 ET · period of report 2022-06-27 · accession 0001209191-22-039808 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-29 | 2022-06-27 | NBIX | Cooke Julie | CHRO | S - Sale | $100.00 | -754 | 16.9K | -4% | -$75.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-27 | S | D | 754 | $100.00 | 16,918 | D | — | — | (F2) Includes an aggregate of 261 shares purchased on February 28, 2022 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. |